National Health Investors, Inc. $NHI Stock Holdings Lifted by Hsbc Holdings PLC

Hsbc Holdings PLC increased its holdings in National Health Investors, Inc. (NYSE:NHI) by 20.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 75,426 shares of the real estate investment trust’s stock after buying an additional 12,947 shares during the period. Hsbc Holdings PLC owned about 0.16% of National Health Investors worth $5,760,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. NewEdge Advisors LLC lifted its holdings in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock worth $114,000 after acquiring an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after acquiring an additional 21,851 shares during the period. Jane Street Group LLC grew its holdings in shares of National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock valued at $5,148,000 after purchasing an additional 65,885 shares during the last quarter. Cetera Investment Advisers grew its holdings in shares of National Health Investors by 6.1% during the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock valued at $336,000 after purchasing an additional 275 shares during the last quarter. Finally, American Century Companies Inc. raised its position in shares of National Health Investors by 2.2% during the 2nd quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after purchasing an additional 420 shares during the period. Institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

NHI has been the topic of several recent research reports. Truist Financial cut their price target on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. BMO Capital Markets lowered their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft cut their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $83.86.

Insider Activity at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by company insiders.

National Health Investors Price Performance

Shares of NYSE:NHI opened at $76.20 on Friday. The firm’s 50 day moving average is $74.23 and its two-hundred day moving average is $79.61. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The firm has a market capitalization of $3.69 billion, a P/E ratio of 24.58, a PEG ratio of 3.44 and a beta of 0.51. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 4.8%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.